Bristol-Myers Squibb BMY Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's total liabilities?
- Bristol-Myers Squibb (BMY) reported total liabilities of $65.32B in Q2 2026.
- How has Bristol-Myers Squibb's total liabilities changed year-over-year?
- Bristol-Myers Squibb's total liabilities decreased by 15.4% year-over-year, from $77.19B to $65.32B.
- What is the long-term trend for Bristol-Myers Squibb's total liabilities?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total liabilities has grown at a -2.4% compound annual growth rate (CAGR), from $80.6B to $71.53B.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.